Results

Total Results: 1,524 records

Showing results for "drugs".

221. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
     October 01, 2014 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … after administration.35 Manufacturer and regulatory status: The drug was launched in 1966 by King Pharmaceuticals … Drugs Future. 2009;34(3):217-21. 31. Research suggests new drug targets for depression. … In: Drugs@FDA [internet]. Silver Spring (MD): U.S.

222. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Drugs that are not approved by the FDA have been removed. … Drugs that are not approved by the FDA have been removed. … Weiglein; Takeda Pharmaceuticals North America, Inc Results 1. … Weiglein; Takeda Pharmaceuticals North America, Inc Results 1. … Weiglein; Takeda Pharmaceuticals North America, Inc Discussion 1.

223. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
     September 01, 2011 - Currently, nine atypical antipsychotic drugs have been approved by FDA: aripiprazole, asenapine, clozapine … These drugs have been used off-label (i.e., for indications not approved by FDA) for the treatment of … While it is legal for a physician to prescribe drugs in such a manner, it is illegal for the manufacturer … How do they compare within the class and with other drugs used for the conditions? … How do they compare within the class and with other drugs used for the conditions?

224. Finding Evidence for Comparing Medical Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
     January 01, 2011 - These approval documents—which can be found at Drugs@FDA.gov—may help identify publication bias even … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. 46. … Ottawa: Canadian Agency for Drugs and Technologies in Health. … an pharmaceuticals, more non-U.S. coverage than MEDLINE Avenell, 2001 Minozzi, 2000 Sampson, … and pharmaceuticals Fishman, 1996 Wolfe, 2002 MANTIS (Manual Alternative and Natural Therapy Index

225. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
     January 01, 2011 - PICO Population(s): Adult patients with PAD and comorbid or multimorbid disease Intervention(s): Drugs

226. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
     January 01, 2006 - Common oral medications for osteoarthritis include nonsteroidal antiinflammatory drugs (NSAIDs) and acetaminophen … Food and Drug Administration (FDA) as pharmaceuticals, including glucosamine and chondroitin, as well … In addition, efficacy and safety may vary for individual drugs within a class. … For this report, we defined the terms “selective NSAIDs” or “COX-2 selective NSAIDs” as drugs in the … We defined “partially selective NSAIDs” as other drugs shown to have partial in vitro COX-2 selectivity

227. Drug Safety | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/drug-safety

228. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … drug in some state Medicare drug plan formularies, which is the highest pricing tier for specialty pharmaceuticals … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2014 Apr 10]. [5 p].

229. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Results The table below lists two topics for which (1) preliminary phase III data for drugs or phase … We continue tracking novel drugs and interventions such as fecal microbiota therapy for ulcerative … Raleigh (NC): Salix Pharmaceuticals, Inc.; 2014 Mar. 19 p. 34. Salix Pharmaceuticals, Inc. … Raliegh (NC): Salix Pharmaceuticals, Inc.; 2015 May. 7 p. … Raleigh (NC): Salix Pharmaceuticals; 1 p.

230. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … available in generic form from several manufacturers, as well as in branded form, as Ketalar® (JHP Pharmaceuticals … CNS Drugs. 2012 Mar 1;26(3):189-204. … PMID: 14640353 http://www.cesar.umd.edu/cesar/drugs/ketamine.pdf http://www.cesar.umd.edu/cesar/drugs … Rochester (MI): JHP Pharmaceuticals, LLC; 2011 Jun. 4 p.

231. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … below lists the three topics for which (1) preliminary phase III or bioequivalence study data for drugs

232. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists the six topics for which (1) preliminary phase III data for drugs, at … of this therapy for both drugs. … Therapeutics, Inc., Hayward, CA), is extended-release exenatide for injection (Bydureon™, Amylin Pharmaceuticals … Get drugs straight to the eye. [internet].

233. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
     April 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The table below lists the three topics for which (1) preliminary phase III were available for drugs … Impact Interventions Report, we aggregated related topics for summary and discussion (e.g., individual drugs

234. Executive Summary_Comparative Effectiveness Review No. 263: Management of Postpartum Hypertensive Disorders of Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
     May 01, 2023 - Two RCTs specifically evaluated end-organ protective effects of two antihypertensive drugs in patients … Because the studies evaluated a large variety of specific drugs and evaluated disparate outcomes, we … evidence related to maternal morbidity and mortality (among two small studies that evaluated different drugs … Trials are needed for the numerous antihypertensive drugs commonly used in practice to allow better

235. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Curr Opin Investig Drugs. 2001 Apr;2(4):505-9. PMID: 11566007 30. Tappenden K, Edelman J. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec [accessed 2013 Jun 5]. [19 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Oct 16 [accessed 2012 Oct 16]. [3 p].

236. Ced-Topic-Refinement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
     November 01, 2022 - Medicare beneficiaries.1 Thus, CMS makes decisions about providing insurance coverage for use of these drugs … For studies that involve researching the safety and effectiveness of new drugs and biological products … For studies that involve researching the safety and effectiveness of new drugs and biological products … there may not be the extensive clinical trial record that is generated during regulatory approval of pharmaceuticals … Specification for Cancer Drugs Fund data collection arrangements.

237. Disposition of Comments Report for Stroke Prevention in Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
     August 23, 2013 - Public Reviewer #1 – Sabine Luik, Boehringer Ingelheim Pharmaceuticals, Inc. … Public Reviewer #1 – Sabine Luik, Boehringer Ingelheim Pharmaceuticals, Inc. … Public Reviewer #1 – Sabine Luik, Boehringer Ingelheim Pharmaceuticals, Inc. … Acknowledged Public Reviewer #1 – Sabine Luik, Boehringer Ingelheim Pharmaceuticals, Inc. … No known reversibility agents for the new drugs. Thank you for this comment.

238. Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-jaw-rapid-response.pdf
     May 01, 2025 - the jaw (MRONJ) before, during, or after treatment with bisphosphonates, antiangiogenics, and other drugs … A growing body of evidence suggests that corticosteroids and anti- angiogenic drugs can exacerbate the … Furthermore, more uses for antiangiogenic drugs are being explored across osteoporosis, such as current … Review and Update on Drugs Related to the Development of Osteonecrosis of the Jaw. … (63) Drugs@FDA: FDA-Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/ daf/index.cfm?

239. Research White Paper Multinational Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - focused on the outcomes, effectiveness, comparative clinical effectiveness, and appropriateness of pharmaceuticals … Food and Drug Administration [FDA], Health Canada, Japanese Pharmaceuticals and Medical Devices Agency … http://www.fda.gov/downloads/Drugs/Drug Safety/ucm089809.pdf. Accessed January 10, 2017. 21. … http://www.fda.gov/downloads/Drugs/Guida nces/ucm073122.pdf. Accessed January 10, 2017. 37. … /downloads/Drugs/DrugSafety/ucm089809.pdf http://www.wma.net/en/30publications/10policies/b3/ http://

240. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
     December 29, 2020 - Dosing of nonsteroidal anti-inflammatory drugs (NSAIDS). … No not everyone who is on an opiod ends up on street drugs. … This war on drugs came into existence during the Nixon era. … We still have more people overdosing on drugs and alcohol than ever before. … It is illegal drugs that are causing our problem and lack of education of our citizens.